TipRanks
Go Ultimate55% OFF

Epigenomics (0QXH) Financial Statements

Epigenomics Financial Overview

Epigenomics's market cap is currently $953.71K. The company's EPS TTM is ―; its P/E ratio is -2.42; Epigenomics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 339.00K$ 485.00K$ 6.20M
Gross Profit$ 282.00K$ 365.00K$ 6.07M
Operating Income$ -4.18M$ -12.05M$ -2.35M
EBITDA$ -2.83M$ -11.22M$ -1.94M
Net Income$ -4.46M$ -12.02M$ -2.43M
Balance Sheet
Cash & Short-Term Investments$ 2.10M$ 10.04M$ 23.05M
Total Assets$ 12.85M$ 15.85M$ 24.66M
Total Debt$ 11.89M$ 841.00K$ 460.00K
Net Debt$ 9.79M$ -9.20M$ -22.59M
Total Liabilities$ 12.85M$ 5.68M$ 2.54M
Stockholders' Equity$ 0.00$ 10.17M$ 22.12M
Cash Flow
Free Cash Flow$ -5.71M$ -13.39M$ -4.19M
Operating Cash Flow$ -5.71M$ -12.02M$ -4.15M
Investing Cash Flow$ 68.00K$ -1.70M$ 961.00K
Financing Cash Flow$ -57.00K$ -359.00K$ 21.62M

Currency in EUR

Epigenomics Earnings and Revenue History

-16M-8M08M-3000 %-2000 %-1000 %0 %EarningsProfit Margin202120222023RevenueEarningsProfit Margin

Epigenomics Debt to Assets

010M20M30M0 %40 %80 %120 %LiabilitiesDebt to Assets202120222023AssetsLiabilitiesDebt to Assets

Epigenomics Cash Flow

-20M-10M010M20M30M202120222023OperatingInvestingFinancing

Epigenomics Forecast EPS vs Actual EPS

-4-3-2-101Q3 24Q1 25Q4 24Q2 25Q2 26EPS EstimateBeatMiss